Navigation Links
Nanovis Awarded Nanotechnology Designation for Bioceramic Nanotube Surface.
Date:10/26/2019

Nanovis today announced that it received the first 510(k) clearance for a bioceramic nanotube surface that demonstrated the FDA requirements for nanotechnology.

“We are delighted to receive such an important designation for this new class of nanotechnology. This nanotechnology plays an important role in achieving Nanovis’ goal to reduce the pain and suffering from implant loosening. With this clearance we can rapidly apply this technology to our entire spinal implant portfolio so that we can help as many patients as possible and promote sales growth for the long-term,” says Nanovis CEO, Matt Hedrick.

Nanovis is an award-winning platform technology-driven growth company committed to helping surgeons and hospitals achieve excellent fixation and infection outcomes using advanced nanotechnology platforms. Its industry-leading fixation technologies offer surgeons and hospitals the best aspects of fixation, visualization, and durability. Nanovis’ developmental infection technology platforms promise to offer surgeons and hospitals much-needed bactericidal solutions.

Nanovis is actively expanding distribution for bioceramic nanotube enhanced Nano FortiCore interbodies. To discuss opportunities, please contact Jeff Shepherd, Vice President of Sales, at Jeff.Shepherd@NanovisTechnology.com.

About Nanovis

Nanovis discovers, develops, and commercializes innovative technology platforms designed for superior fixation and infection outcomes. Nanovis is commercializing the following innovative technology platforms: a bioceramic enhanced nanotube surface, a deeply porous titanium scaffold (licensed from Sites Medical), an advanced bioceramic bactericidal nanotube surface technology in pre-clinical studies, and a pre-clinical localized infection technology targeting anti-microbial resistant bacteria.

If you would like more information about Nanovis, please contact:

Guillaume Viallaneix
MedTech Momentum
(407) 960-2994
info@medtechmomentum.com

Read the full story at https://www.prweb.com/releases/nanovis_awarded_nanotechnology_designation_for_bioceramic_nanotube_surface/prweb16666082.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Scientists awarded $5.5 million for wheat, rice blast research
2. University of Houston engineering professor awarded grant to study melanoma treatment
3. Bowman Design Group is first US company awarded German FAMAB Sustainable Company certification
4. Vijay Tiwari awarded the Bruno Speck Award 2013
5. Patent awarded today to NJIT for novel use of water jets to create high tensile strength alloy parts
6. Kessler Foundation awarded more than $1.2 million in grants by the NJ Commission on Sci Research
7. LSUHSC researcher awarded NCI grant to study link between chronic inflammation and cancer
8. HudsonAlpha awarded grant to improve diagnoses of childhood genetic disorders
9. MIIR scientist awarded $293,000 NIH grant
10. Professor Vanessa Hayes awarded for exceptional Africa-related work
11. 4 projects awarded Discovery Transformation Grant funding by Minnesota Partnership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2019)... ... November 27, 2019 , ... The ... with surface electromyography (sEMG) sensors that measure and display muscle activity in real ... muscles being targeted for treatment. Both patient and therapist can see when exercises ...
(Date:11/19/2019)... ... November 19, 2019 , ... Project Lifeline – a community partnership ... to address substance use disorder (SUD) – will take center stage at ... to the program’s effectiveness in preventing and treating opioid abuse in Blair County, Pennsylvania, ...
(Date:11/19/2019)... ... 2019 , ... Hosted at the Las Vegas Convention Center, and brought to ... largest gathering of MJBiz business professionals in the world. With over 1,300 exhibitors from ... is no show quite like it. Atlantic Ultraviolet will exhibit at Booth C9217, showcasing ...
Breaking Biology News(10 mins):
(Date:11/9/2019)... , ... November 08, 2019 ... ... artificial intelligence (AI)-powered technology for use in pathology research, today announced the ... biopsy samples from patients enrolled in the phase 3 selonsertib studies (STELLAR). ...
(Date:11/6/2019)... , ... November 06, 2019 , ... ... through off-the-record collaboration and dialogue, today announces its East/West CEO conference ... in San Francisco. , Kicking off the week of the J.P. ...
(Date:11/5/2019)... ... November 05, 2019 , ... Focal Healthcare ... Mark for its Fusion Bx 2.0 prostate fusion biopsy solution. By combining information ... Bx 2.0 will give urologists across Europe the ability to perform targeted transrectal ...
(Date:11/2/2019)... ... October 31, 2019 , ... A ... communicating with each other: study managers, principal investigators, supply chain managers, manufacturers, IRT, ... is not informed of the latest data, potentially leading to patient risk. , ...
Breaking Biology Technology: